Evaluating the complexity of the immune response to vidutolimod
Iowa Research Online (The University of Iowa) · 26.04.2023
DOI: 10.25820/etd.006993 ↗Kurz gefasst
Fachartikel in der Zeitschrift Iowa Research Online (The University of Iowa), erschienen am 26.04.2023. Verfasst von Shakoora A. Sabree.
Abstract (Originalsprache)
Recent advances in cancer immunotherapy were recognized by the 2019 Nobel Prizes in Biomedicine, and show exciting new potential to greatly improve patient outcomes. However, many patients fail to mount a clinically meaningful anti-tumor immune response with current immunotherapies. In situ immunization is an immunotherapy strategy with the potential to overcome this limitation by altering the tumor microenvironment (TME) in a manner that allows for the generation of a tumor-specific immune response.
Schlagwörter
Zitieren
APA
Sabree, S. A. (2023). Evaluating the complexity of the immune response to vidutolimod. Iowa Research Online (The University of Iowa). https://doi.org/10.25820/etd.006993
Vancouver
Sabree SA. Evaluating the complexity of the immune response to vidutolimod. Iowa Research Online (The University of Iowa). 2023. doi:10.25820/etd.006993
BibTeX
@article{Sabree2023,
author = {Sabree, Shakoora A.},
title = {Evaluating the complexity of the immune response to vidutolimod},
journal = {Iowa Research Online (The University of Iowa)},
year = {2023},
doi = {10.25820/etd.006993}
}
EUVIMED